Arixtra

Jump to

Dr Reddy's Labs to buy IP rights of fondaparinux

Australian drug discovery and development company Alchemia Ltd has entered into an agreement for sale of exclusive intellectual property rights of fondaparinux sodium to Dr Reddy's Laboratories (DRL), for USD 17.5 million.
Dr Reddy's gets USFDA ok for deep vein thrombosis injection

Dr Reddy’s Laboratories has received final approval from the US Food and Drugs Administration (FDA) to sell Fondaparinux Sodium injection, which is used for the treatment and prevention of deep vein thrombosis (DVT).
To improve market share, position in Germany: Dr Reddy's

GV Prasad, Vice Chairman and CEO, Dr Reddys Laboratories in an interview with CNBC-TV18 spoke about the quarterly numbers of the company and the road ahead.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Arixtra

Dr Reddy's Labs to buy IP rights of fondaparinux

Dr Reddy's gets USFDA ok for deep vein thrombosis injection

To improve market share, position in Germany: Dr Reddy's